TY - JOUR
T1 - Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe
T2 - The PanCareSurFup study
AU - Reulen, Raoul C.
AU - Wong, Kwok F.
AU - Bright, Chloe J.
AU - Winter, David L.
AU - Alessi, Daniela
AU - Allodji, Rodrigue M.
AU - Bagnasco, Francesca
AU - Bárdi, Edit
AU - Bautz, Andrea
AU - Byrne, Julianne
AU - Feijen, Elizabeth A.M.
AU - Fidler-Benaoudia, Miranda M.
AU - Diallo, Ibrahim
AU - Garwicz, Stanislaw
AU - Grabow, Desiree
AU - Gudmundsdottir, Thorgerdur
AU - Guha, Joyeeta
AU - Haddy, Nadia
AU - Høgsholt, Stine
AU - Jankovic, Moncilo
AU - Kaatsch, Peter
AU - Kaiser, Melanie
AU - Kuonen, Rahel
AU - Linge, Helena
AU - Øfstaas, Hilde
AU - Ronckers, Cecile M.
AU - Hau, Eva Maria
AU - Skinner, Roderick
AU - Van Leeuwen, Flora E.
AU - Teepen, Jop C.
AU - Veres, Cristina
AU - Zrafi, Wael
AU - Debiche, Ghazi
AU - Llanas, Damien
AU - Terenziani, Monica
AU - Vu-Bezin, Giao
AU - Wesenberg, Finn
AU - Wiebe, Thomas
AU - Sacerdote, Carlotta
AU - Jakab, Zsuzsanna
AU - Haupt, Riccardo
AU - Lähteenmäki, Päivi M.
AU - Zadravec Zaletel, Lorna
AU - Kuehni, Claudia E.
AU - Winther, Jeanette F.
AU - De Vathaire, Florent
AU - Kremer, Leontien C.
AU - Hjorth, Lars
AU - Hawkins, Michael M.
N1 - Publisher Copyright:
©
PY - 2021/8/1
Y1 - 2021/8/1
N2 - Background Survivors of childhood cancer are at risk of subsequent primary neoplasms (SPNs), but the risk of developing specific digestive SPNs beyond age 40 years remains uncertain. We investigated risks of specific digestive SPNs within the largest available cohort worldwide. Methods The PanCareSurFup cohort includes 69 460 five-year survivors of childhood cancer from 12 countries in Europe. Risks of digestive SPNs were quantified using standardised incidence ratios (SIRs), absolute excess risks and cumulative incidence. Results 427 digestive SPNs (214 colorectal, 62 liver, 48 stomach, 44 pancreas, 59 other) were diagnosed in 413 survivors. Wilms tumour (WT) and Hodgkin lymphoma (HL) survivors were at greatest risk (SIR 12.1; 95% CI 9.6 to 15.1; SIR 7.3; 95% CI 5.9 to 9.0, respectively). The cumulative incidence increased the most steeply with increasing age for WT survivors, reaching 7.4% by age 55% and 9.6% by age 60 years (1.0% expected based on general population rates). Regarding colorectal SPNs, WT and HL survivors were at greatest risk; both seven times that expected. By age 55 years, 2.3% of both WT (95% CI 1.4 to 3.9) and HL (95% CI 1.6 to 3.2) survivors had developed a colorectal SPN - comparable to the risk among members of the general population with at least two first-degree relatives affected. Conclusions Colonoscopy surveillance before age 55 is recommended in many European countries for individuals with a family history of colorectal cancer, but not for WT and HL survivors despite a comparable risk profile. Clinically, serious consideration should be given to the implementation of colonoscopy surveillance while further evaluation of its benefits, harms and cost-effectiveness in WT and HL survivors is undertaken.
AB - Background Survivors of childhood cancer are at risk of subsequent primary neoplasms (SPNs), but the risk of developing specific digestive SPNs beyond age 40 years remains uncertain. We investigated risks of specific digestive SPNs within the largest available cohort worldwide. Methods The PanCareSurFup cohort includes 69 460 five-year survivors of childhood cancer from 12 countries in Europe. Risks of digestive SPNs were quantified using standardised incidence ratios (SIRs), absolute excess risks and cumulative incidence. Results 427 digestive SPNs (214 colorectal, 62 liver, 48 stomach, 44 pancreas, 59 other) were diagnosed in 413 survivors. Wilms tumour (WT) and Hodgkin lymphoma (HL) survivors were at greatest risk (SIR 12.1; 95% CI 9.6 to 15.1; SIR 7.3; 95% CI 5.9 to 9.0, respectively). The cumulative incidence increased the most steeply with increasing age for WT survivors, reaching 7.4% by age 55% and 9.6% by age 60 years (1.0% expected based on general population rates). Regarding colorectal SPNs, WT and HL survivors were at greatest risk; both seven times that expected. By age 55 years, 2.3% of both WT (95% CI 1.4 to 3.9) and HL (95% CI 1.6 to 3.2) survivors had developed a colorectal SPN - comparable to the risk among members of the general population with at least two first-degree relatives affected. Conclusions Colonoscopy surveillance before age 55 is recommended in many European countries for individuals with a family history of colorectal cancer, but not for WT and HL survivors despite a comparable risk profile. Clinically, serious consideration should be given to the implementation of colonoscopy surveillance while further evaluation of its benefits, harms and cost-effectiveness in WT and HL survivors is undertaken.
KW - CANCER EPIDEMIOLOGY
KW - COLORECTAL CANCER
KW - COLORECTAL CANCER SCREENING
KW - GASTROINTESTINAL CANCER
UR - http://www.scopus.com/inward/record.url?scp=85095995713&partnerID=8YFLogxK
U2 - 10.1136/gutjnl-2020-322237
DO - 10.1136/gutjnl-2020-322237
M3 - Article
C2 - 33139271
AN - SCOPUS:85095995713
SN - 0017-5749
VL - 70
SP - 1520
EP - 1528
JO - Gut
JF - Gut
IS - 8
ER -